Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products

Ashish Sharma, Benjamin Weber, Martina Wein, Christoph Hallmann, Bernd Meibohm

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)52-56
Number of pages5
JournalClinical Pharmacology in Drug Development
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Therapeutic Equivalency
Chronic Obstructive Pulmonary Disease
Asthma
Pharmacokinetics
Tiotropium Bromide

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products. / Sharma, Ashish; Weber, Benjamin; Wein, Martina; Hallmann, Christoph; Meibohm, Bernd.

In: Clinical Pharmacology in Drug Development, Vol. 5, No. 1, 01.01.2016, p. 52-56.

Research output: Contribution to journalArticle

Sharma, Ashish ; Weber, Benjamin ; Wein, Martina ; Hallmann, Christoph ; Meibohm, Bernd. / Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products. In: Clinical Pharmacology in Drug Development. 2016 ; Vol. 5, No. 1. pp. 52-56.
@article{5e6eb0f15d9343db900eb3802c4a0678,
title = "Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products",
author = "Ashish Sharma and Benjamin Weber and Martina Wein and Christoph Hallmann and Bernd Meibohm",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/cpdd.187",
language = "English (US)",
volume = "5",
pages = "52--56",
journal = "Clinical Pharmacology in Drug Development",
issn = "2160-763X",
publisher = "Sage Periodicals Press",
number = "1",

}

TY - JOUR

T1 - Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products

AU - Sharma, Ashish

AU - Weber, Benjamin

AU - Wein, Martina

AU - Hallmann, Christoph

AU - Meibohm, Bernd

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84954558308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954558308&partnerID=8YFLogxK

U2 - 10.1002/cpdd.187

DO - 10.1002/cpdd.187

M3 - Article

VL - 5

SP - 52

EP - 56

JO - Clinical Pharmacology in Drug Development

JF - Clinical Pharmacology in Drug Development

SN - 2160-763X

IS - 1

ER -